Skip to content
The Nexus
DossierENTITY

direct tumor injection

Coverage of direct tumor injection in the Nexus archive.

Earliest in view: Apr 29 · 00:00 UTCMost recent: Apr 29 · 00:00 UTC
Co-mentioned in this coverage
Natureorganization1anticancer immunotherapytopic1advanced skin cancertopic1intravenous administrationtopic1immune toxicitytopic1antitumor efficacytopic1biomarkerstopic1
Recent coverage
  • HEALTHApr 29 · 00:00 UTCNATURE NEWS
    Delivering an immune therapy into tumours instead of intravenously reduces adverse effects

    A study found that injecting low doses of anticancer immunotherapy directly into tumors in advanced skin cancer patients reduced severe immune toxicity compared to high-dose intravenous administration, while maintaining antitumor efficacy. Pre-existing antitumor immunity was the strongest predictor of clinical benefit, and fresh tissue profiling provided faster biomarker results than conventional diagnostics.